Clinical Trials Directory

Trials / Unknown

UnknownNCT04674592

Biomarkers in the Diagnosis of Acute Compartment Syndrome

Biomarkers of Rhabdomyolysis in the Diagnosis of Acute Compartment Syndrome: Study Protocol of a Prospective Multinational, Multicentre Study in Patients With Tibial Fractures.

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
University Hospital, Linkoeping · Academic / Other
Sex
All
Age
15 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This prospective multinational, multicentre cohort study aims to investigate the hypothesis that biomarkers of muscle cell damage can predict acute compartment syndrome in patients with tibial fractures.

Detailed description

Patients with a tibial fracture are included. P-myoglobin and P-creatine phosphokinase are analysed at 6-hourly intervals pre- and if applicable, postoperatively after surgical fixation or fasciotomy. Also, blood samples will be collected in 6 hourly intervals if acute compartment syndrome is suspected. An expert panel of senior orthopaedic surgeons will retrospectively assess study data and classify patients who had undergone fasciotomy into those with and without acute compartment syndrome. Blood samples will also be collected in patients with acute compartment syndrome without tibial fractures, to serve as a positive control group.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples and biopsiesBlood samples for analysis of biomarkers of muscle damage. Muscle biopsies for histological analysis of muscle damage.

Timeline

Start date
2018-04-05
Primary completion
2023-06-01
Completion
2024-12-01
First posted
2020-12-19
Last updated
2022-11-02

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04674592. Inclusion in this directory is not an endorsement.